Serum Institute to produce up to additional 100 mn COVID-19 vaccine doses for India and LMIC in 2021 Read more
Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile idiopathic arthritis Read more
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData Read more